Your cart is currently empty!
FDA Approves New Pancreatic Cancer Drug After Trial Nearly Doubled Median Survival
A new treatment has been approved for one of the most difficult cancers to treat, and the clinical trial results behind the decision are already drawing major attention. The FDA has approved Rasonque, also known as daraxonrasib, for certain adults with advanced pancreatic cancer after a study found that patients taking the drug had a…